(Q57557750)

Daniela Dušková

9

0 references

Lenka Záveská Drábková

Lenka Záveská Drábková

6

0 references

Milada Kohoutova

Milada Kohoutová

12

0 references

Ales Horínek

Aleš Hořínek

8

0 references

author name string

Luděk Záveský

1

0 references

Eva Jandáková

2

0 references

Lucie Langmeierová

4

0 references

Vít Weinberger

5

0 references

Martina Hůlková

7

0 references

Jaroslav Feyereisl

10

0 references

Luboš Minář

Pathology Oncology Research

11

0 references

publication date

1 April 2015

0 references

published in

0 references

volume

21

0 references

issue

4

0 references

page(s)

1027-1035

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Ovarian cancer: origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Circulating MicroRNAs in gynecological malignancies: from detection to prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

The MicroRNA Spectrum in 12 Body Fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Expression of microRNAs in the urine of patients with bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Comprehensive algorithm for quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

A new real-time PCR method to overcome significant quantitative inaccuracy due to slight amplification inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Potential role of miR-9 and miR-223 in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-015-9914-Y

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25827090

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25827090